丰倍生物开启申购 现有生物柴油产能10.5万吨

Core Viewpoint - Fengbei Bio (603334.SH) has initiated its subscription with an issue price of 24.49 CNY per share and a maximum subscription limit of 11,000 shares, reflecting a price-to-earnings ratio of 30.47 times. The company operates in the waste resource utilization sector, focusing on converting waste oils into biofuels and biobased materials, establishing a comprehensive recycling industry chain [1]. Company Overview - Fengbei Bio is a high-tech enterprise specializing in the comprehensive utilization of waste resources, primarily focusing on waste oils to produce biobased products and biofuels. The main products include biobased materials such as pesticide and fertilizer additives, and biofuels like biodiesel [1]. - The company has established long-term partnerships with leading agricultural chemical firms, including Fengle Seed Industry, Jiuyi Co., Lutianhua, Sichuan Meifeng, and Batian Co. [1]. Production Capacity - As of the end of 2024, Fengbei Bio's biodiesel production capacity is 105,000 tons, ranking sixth in China's biodiesel industry. Compared to peers like Zhuoyue New Energy and Jiaao Environmental Protection, Fengbei's net profit after deducting non-recurring gains is lower than Zhuoyue but higher than Jiaao and Longhai Bio [2][3]. Financial Performance - The company reported revenues of approximately 1.709 billion CNY, 1.728 billion CNY, and 1.949 billion CNY for the years 2022, 2023, and 2024, respectively. Net profits for the same years were approximately 133 million CNY, 130 million CNY, and 124 million CNY [2][4]. - Total assets as of December 31, 2024, are 12.368 billion CNY, with equity attributable to shareholders at 7.558 billion CNY. The asset-liability ratio has improved from 49.12% in 2022 to 43.13% in 2024 [4]. Profitability Metrics - For the fiscal year 2024, the company expects a net profit of approximately 1.238 billion CNY, with a basic earnings per share of 1.15 CNY. The return on equity is projected at 17.91%, down from 30.57% in 2022 [5].